Shared by
beno
Fundamentals
N/a
Catalysts / News / Painting the picture
-Corona virus sympathy
-Health officials say virus vaccine development has 'no glitches'
-Feb 11 2020: $500m IPO @ $19 per share
-mRNA-1273 coronavirus vaccine sent for testing
-March 16 2020: First human trial of COVID-19 vaccine
-April 15 2020: PT increase to 41, Making new ATH's
-April 16 2020: Wins $483 Million US Government Award To Develop Coronavirus Vaccine
Technical Analysis
-Intraday pattern: Consolidation
-Levels: 43.5, 45, 47, 48, 50
Original Plan / Strategy
First test short of 47.5 level with half dollar confluence
Review
Not much confluence so took it with small size, scratched one lot because stock was holding up pretty well and took profits on the other lot making for a small green trade.
Execution detail:
| Date/time | Symbol | Side | Price | Position |
|---|---|---|---|---|
| 2020-04-17 13:29:04 | MRNA | sell | $47.250 | short |
| 2020-04-17 13:29:11 | MRNA | sell | $47.330 | short |
| 2020-04-17 13:31:36 | MRNA | buy | $47.250 | short |
| 2020-04-17 13:33:01 | MRNA | buy | $47.100 | short |
| 2020-04-17 13:33:01 | MRNA | buy | $47.100 | 0 |
Leave a comment about this trade!
You need to log into your Tradervue account to leave a comment. If you don't have one,
it takes
just a few seconds to sign up, and it's free!